![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/08/BMS-582949-is-an-Orally-Active-p38α-MAPK-Inhibitor-2019-08-23.jpg)
BMS-582949 was identified as a highly selective p38α MAP kinase inhibitor as early in 2010. Moreover, it has entered into…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/08/FR167653-an-Orally-Active-p38-MAPK-Inhibitor-Inhibits-Cytokine-Production-2019-08-05.jpg)
Various types of cytokinesuchemokines react with their receptors. They transduce extracellular signals into intracellular response through a mitogen-activated protein kinase…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/08/MW-150-an-Orally-Active-p38α-MAPK-Inhibitor-Modulates-Cytokine-Production-and-Cognitive-Outcomes-2019-08-04.jpg)
Currently, a void exists for serine/threonine protein kinase inhibitor drugs and central nervous system indications. Stress kinases are of special…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/08/SD-0006-is-an-Orally-Active-MAPK-p38α-Inhibitor-for-the-Treatment-of-Rheumatoid-Arthritis-2019-08-02.jpg)
In previous blogs, we have introduced a few MAPK p38 inhibitors. As a result, MAPK p38 plays an important role…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/07/AL-8697-is-an-Orally-Active-and-Specific-p38α-MAPK-Inhibitor-2019-07-17.jpg)
A wide range of cellular stresses can activate mammalian p38 MAPKs, or it is in response to inflammatory cytokines. The…